Three rabbit study: (1) dose range finding study in rabbits via oral gavage (non-GLP); (2) preliminary embryo fetal developmental study in rabbits via oral gavage (non-GLP); (3) embryo fetal…
Ended Awarded Last action
- Contract number
- 75N91018F00004
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $487,537
Award facts
- Opportunity
-
- N02CM4700142 Solicitation number
- Preclinical toxicology of drugs developed for cancer patients Award Notice · Posted Jul 6, 2016
- Preclinical toxicology of drugs developed for cancer patients Award Notice · Posted Apr 4, 2014
- Contract value 100% obligated
- $487,537.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $51,961 | |
| Original award | $435,576 |
About this award
The National Cancer Institute issued a delivery order to IIT Research Institute on September 5, 2018, under the Toxicology of Drugs Developed for Cancer Patients IDIQ with a ceiling value of $487,537, to conduct three rabbit developmental toxicology studies via oral gavage—a dose range-finding study (non-GLP), a preliminary embryo-fetal developmental study (non-GLP), and a pivotal embryo-fetal developmental study in New Zealand White rabbits (GLP).
Place of performance is Chicago, IL. The order was structured as cost-plus-fixed-fee and carried an ultimate completion date of June 30, 2021. No set-aside applied. Service Contract Inventory records show minimal invoiced activity: $290,000 in FY2020 and 2 contractor hours in FY2021 with no reported FTE allocation or subcontractor support.
Description
Three rabbit study: (1) dose range finding study in rabbits via oral gavage (non-GLP); (2) preliminary embryo fetal developmental study in rabbits via oral gavage (non-GLP); (3) embryo fetal developmental study in new zealand white rabbits via oral gavage (GLP))
Quick answers
Who was awarded contract 75N91018F00004?
75N91018F00004 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on September 5, 2018.
How much is contract 75N91018F00004 worth?
The government has obligated $487,537 on 75N91018F00004.
Is contract 75N91018F00004 an order under another contract?
Yes. 75N91018F00004 is a delivery order under HHSN261201600015I, an indefinite delivery contract, on Toxicology of Drugs Developed for Cancer Patients.
Was contract 75N91018F00004 competed?
The extent of competition for 75N91018F00004 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award